- The Washington Times - Wednesday, May 10, 2006

The Washington Times on April 28 incorrectly reported the approval process for a test that provides an accurate prediction of a man’s risk for recurrent prostate cancer. Food and Drug Administration approval is not required for the diagnostic test Prostate PX.


Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide